Filtered By:
Cancer: Lymphoma
Therapy: Palliative

This page shows you your search results in order of date.

Order by Relevance | Date

Total 184 results found since Jan 2013.

Targeted therapy and immunotherapy for orbital and periorbital tumors: a major review
This article will focus on recent updates in the application of available targeted and immunotherapy for managing orbital and periorbital tumors and tumor-like conditions, which include cutaneous basal cell carcinoma, cutaneous squamous cell carcinoma, cutaneous melanoma, Merkel cell carcinoma, sebaceous gland carcinoma, solitary fibrous tumor, dermatofibrosarcoma protuberans, orbital meningioma, neurofibromatosis, Langerhans cell histiocytosis, ocular adnexal lymphoma, orbital lymphatic malformation, and adenoid cystic carcinoma.PMID:37728602 | DOI:10.1080/01676830.2023.2256848
Source: Orbit - September 20, 2023 Category: Opthalmology Authors: Emmanuel Lee Boniao Richard C Allen Gangadhara Sundar Source Type: research

Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain
CONCLUSION: The results of this study suggest that lorlatinib may be a dominant treatment option versus alectinib. Considering a willingness-to-pay threshold of €25,000/QALY, lorlatinib may be an efficient option compared to brigatinib.PMID:37701861 | PMC:PMC10494862 | DOI:10.2147/CEOR.S415711
Source: Cell Research - September 13, 2023 Category: Cytology Authors: Mar ía Presa David Vicente Antonio Calles Laura Salinas-Ortega Jaesh Naik Luis F Garc ía Javier Soto Source Type: research

Living with a blood cancer in later life: The complex challenges and related support needs of adults aged 75 and older
This study investigated the challenges and support needs of adults aged 75 and older during and after treatment for a blood cancer to aid targeted supportive resource development.METHODS: Adults aged 75 and older with a blood cancer participated in in-depth, semi-structured interviews about challenges and unmet support needs. Participants recruited through The Leukemia & Lymphoma Society were (1) in treatment or previously in treatment for a blood cancer at age 75 or older and (2) living in the United States or its territories. A thematic analysis was conducted with findings compared between 2 groups: (1) chronic -livi...
Source: Palliative and Supportive Care - August 22, 2023 Category: Palliative Care Authors: Naomi D Parker Easton N Wollney Carma L Bylund Tithi B Amin M Devyn Mullis Diliara Bagautdinova Maria Sae-Hau Elisa S Weiss Lyndsey A Thomas Carla L Fisher Source Type: research

Radiotherapy in the management of rare gastrointestinal cancers: A systematic review
In conclusion, radiotherapy is not an uncommon indication in this context. A multidisciplinary approach is needed for better management of digestive rare cancers.PMID:37500390 | DOI:10.1016/j.canrad.2023.06.010
Source: Cancer Radiotherapie - July 27, 2023 Category: Cancer & Oncology Authors: F Z Bellefkih N Benchakroun I Lalya B Amaoui H El Kacemi A Acharki M El Hfid A El Mazghi T Chekrine Z Bouchbika H Jouhadi S Sahraoui N Tawfiq M Michalet Source Type: research

A long-term retrospective observational study at a medium-sized medical oncology service in Switzerland: comparison of overall survival with a national cohort and adherence to treatment guidelines
CONCLUSIONS: The statistically comparable local 1- and 5-year overall survival of the analysed malignancies, with adjustment for stage for the 5-year overall survival for breast cancer, is in line with the national benchmark. Adherence to treatment guidelines is high.PMID:37459836 | DOI:10.57187/smw.2023.40091
Source: Swiss Medical Weekly - July 17, 2023 Category: General Medicine Authors: Mirjam Gross-Erne Lukas Zimmerli Stefano Bassetti Qiyu Li Anita Feller Walter Mingrone Source Type: research

A Pancreatic Collision Tumor Comprising Mantle Cell Lymphoma and Adenocarcinoma: A Case Report and Literature Review
Intern Med. 2023 Jun 28. doi: 10.2169/internalmedicine.1937-23. Online ahead of print.ABSTRACTA collision tumor is a rare clinical condition where two different tumors occur synchronically within a lesion. Pancreatic collision tumors with mantle cell lymphoma (MCL) are extremely rare and have only been reported in one case to date. We herein report an elderly patient with MCL and adenocarcinoma of the pancreas with Ann Arbor stage IV and Union for International Cancer Control stage IIB, respectively. The patient received palliative therapy and died 23 months after the diagnosis. Further research and case studies are requir...
Source: Cancer Control - June 28, 2023 Category: Cancer & Oncology Authors: Ryo Sugaya Ai Taniguchi Makoto Abe Iwao Ozawa Keita Kirito Shuji Hatakeyama Source Type: research